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INTRODUCTION 
Short duration of fever with jaundice is one of the common 
clinical scenarios that we come across in medical wards. Most 
common etiological agent responsible for such clinical scenarios are 
Leptospirosis, Malaria and viral hepatitis. 
Other uncommon causes like Cholangitis, Sepsis, Dengue 
fever, Enteric fever, viruses like Human Immunodeficiency Virus 
(HIV), Epstein-Barr Virus (EBV), Cytomegalo Virus (CMV), and 
Varicella - Zoster Virus (VZV). Other non-infective causes like 
alcoholic hepatitis, drug-induced hepatitis and haemolytic uremic 
syndrome also presents with fever and jaundice. 
The pattern of etiological agents also varies according to 
locality. According to Sharad Shah et al21 and Chrideep et al from 
Mumbai, Viral Hepatitis is most common in this scenario, then 
Malaria and third occupied by Leptospirosis. But WHO bulletin7 
state that Leptospirosis prevalence is more common in South India. 
Therefore Leptospirosis must occupy the first place in South India. 
Etiological pattern has to be analysed according to locality. 
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Leptospirosis is the World Wide Zoonotic infection with much 
greater incidence in tropical regions. Epidemiology of Leptospirosis 
has been modified by changes in animal husbandry, climate and 
human behaviours. The incidence of Leptospirosis is remarkably, 
underestimated and the disease underdiagnosed in endemic regions. 
The case fatality rate is 5-25%. 
S.K. Mishra et al23 says that 300 to 400 million cases of 
Malaria diagnosed yearly and of these 1.5 - 2 million died annually. 
90% of world Malarial cases are from tropical Africa and other 10% 
from 3 countries like India, Sri Lanka and Brazil. Of all the malarial 
cases in South-East Asia, India constitute 80% Chloroquine-resistant 
Malaria is in increased prevalence and concept of ACT therapy are 
now in use. 
Early treatment in leptospirosis and Malaria, favour prognosis. 
Therefore always there will be high degree of suspicion to diagnose 
these diseases. 
WHO, 200420 made a statement “more people die of Hepatitis-
B in a day than AIDS in an entire year”. National prevalence rate of 
Hepatitis B was 4.7%, while that of AIDS is less than 1%. 
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Though Viral hepatitis most of the times need only 
symptomatic treatment, it is under estimated in our country and now 
started given importance to this disease. 
The study shows etiological analysis of patients present with 
short duration of fever and jaundice, admitted in Government 
General Hospital, Chennai and clinical profile of Leptospirosis. 
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AIMS AND OBJECTIVES 
1. To analysis the incidence of various etiological agents 
for patients get hospitalised in Government General 
Hospital, Chennai with unexplained fever and jaundice 
of short duration. 
2. To analyse relevant epidemiological data like seasonal 
variation, incidence, clinical profile, biochemical 
investigation and incidence of complications on 
Leptospirosis positive cases. 
3. To analyse the immunisation status of Hepatitis B on 
patients with fever and jaundice. 
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REVIEW OF LITERATURE 
LEPTOSPIROSIS 
Severe leptospirosis is otherwise called Weil’s disease, 
Haemorrhagic Jaundice, Mud fever, Swineherd disease, canicola 
fever, seven-day fever in Japan, cane cutter’s disease in Australia, 
Rice field heptospirosis in Indonesia, Fort Bragg fever in US and 
Andaman Haemorrhagic fever in Andaman. 
HISTORY: 
In 1883, Leptospirosis was recognised as an occupational 
diseases in Sewer workers. In 1886, first description by Weil, 
Professor of Medicine at Heidelberg, of the clinical manifestation 
seen in men (Severe Jaundice, fever and haemorrhage with renal 
involvement). 
Stimson33 in 1907, demonstrated by Silver staining, the 
presence of clumps of spirochetes in the kidney tubules of the 
patient who reportedly died of yellow fever. 
Etiology of Leptospirosis was demonstrated independently in 
1915 in Japan and Germany. In Japan, Inada and Ido36 detected 
both spirochetes and specific antibodies in the blood of Japanese 
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miners with infectious Jaundice and two groups German Physicians 
studied german soldiers afflicted by ‘French disease’ in the trenches 
of North East France. 
Noguchi36 proposed the name ‘Leptospira’ in 1918. 
TAXONOMY AND CLASSIFICATION: 
Serological Classification: 
Prior to 1989, the Genus Leptospira was divided into two 
species, L.Interrogans, comprising all pathological strains and 
L.biflexa, containing the saprophytic strains. 
L. Biflexa was differentiated from L. interrogans by the 
growth of the former at 13oC and growth in the presence of 8-
azaguanine and by the failure of L.biflexa to form special cells in 
1M Nacl. 
Over 60 serovars of L.biflexa have been recorded. Within the 
species L-interrogans over 200 serovars are recognised. 
GENOTYPIC CLASSIFICATION: 
The phenotypic classification of leptospires has been replaced 
by a genotypic one in which a number of genomespecies include all 
serovars of both L-interrogans and L.biflexa. 
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Genospecies of Leptospira and Distribution of Serogroups: 
Table - 1 
S.No Species Serogroups 
1. L.interrogans Icterohemorrhagiae, canicola, Pomona, 
australis, autumnalis, pyrogenes, 
Grippotyphosa, Djasiman, Hebdomadis etc. 
2. L.noguchi Panama, autumnalis, pyrogenes, Tarassori, 
Australis, Shermani, Pomona. 
3. L.santarosai Shermani, Hebdomadis, pyrogenes, 
Autumnalis 
4. L.meyeri Ranarum, Semaranga, Seiroe, Mini 
5. L.wolbachii Codice 
6. L.biflexa Semaranga, Andamana 
7. L.fainei Hurstbridge 
8. L.borgpetersenii Javanica, Ballum, Hebdomadis, Seiroe, 
Tarassovi, Mini 
9. L.kirschneri Grippotyphosa, autumnalis, cynopteri, 
Hebdomadis etc. 
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10. L. Weilii Celledoni, icterohaemorrhagiae, Sarmin 
11. L.inadai Lyme, Shermani, icterohaemorrhagiae 
12. L. Parva Turnesia 
13. L.alexanderi Manhao, Hebdomadi, Javanica 
After studying several hundred strains, workers at centers for 
Disease Control (CDC) more recently defined 16 genospecies of 
Leptospira. 
Biology of Leptospires: 
Leptospire is tightly coiled spirochetes, usually 0.1µm by 6 to 
0.1 by 20µm. Two axial filaments with polar insertion are located in 
the periplasmic space. 
Leptospires are obligate aerobes with an optimum growth 
temperature of 280 - 30oC. It produces both catalase and oxidase. 
It grows in simple media enriched with vitamins (Vit B2 & B12 
are growth factor), long chain fatty acid, and ammonium salt. Most 
widely used medium oleic acid - albumin medium EMJH. It contains 
Tween 80 and bovine serum albumin. 
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EPIDEMIOLOGY: 
Animal Reserviors: 
Mammals are most important animal reservoirs. Leptospires 
are parasites of both wild and domestic animals. Wild variety of 
animals serve as a source of infection like rats, field mice, hedgehog, 
fox, mongoose, deer and domestic animals like cattle, sheep, goats 
and poultry. 
In infected animals, initial Leptospiremic phase followed by a 
period in which organism confined to kidney. Leptospires are 
excreted in the urine and animal acts as a carrier. Man is accidental 
host. 
It is well known that particular host species may severe as a 
reservoir for one or more serotypes of Leptospires and conversely a 
given serotype may be hosted by multiple animal species. Serovars 
most frequently associated with rodents are icterohemorrhagiae and 
autumnalis, cattle are pomana and tarassori, sheep and goats are 
Pomona and grippotyphosa and dogs are canicola and 
icterohemorrhagiae. 
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TRANSMISSION TO HUMAN HOST: 
Direct– by contact with blood, tissue, organs and urine of 
infected animals. 
Indirect– by exposure to an environment contaminated with 
Leptospires, water and soil contaminated with 
infected urine. 
Human to Human transmission rare. 
Factors favouring survivals of leptospices are moistures, 
temperature 28-32oC, pH of the soil and surface water 6.2-8. Factors 
impede the survivals are salinity, chemical pollution and acidic pH. 
Flooding after heavy rain is particularly favourable for 
Leptospirosis. It can survive few hours in dry solid but can survive 
upto 6 months in flooded conditions. Rats urine contamination of 
water in wells remains an important mode for the transmission of 
Leptospires to man. 
In Chennai7, high rainfall and outdoor manual occupation 
encourages higher incidence rate of Leptospirosis and that more 
specific source cannot be pinpointed with certainty. 
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PATHOLOGY AND PATHOGENESIS: 
Leptospira penetrate intact mucous membranes and abraded 
skin and disseminate widely via the blood stream. It produces 
infectious vasculitis, with damage to capillary endothelial cells 
responsible for major clinical manifestations of disease including 
renal tubular and hepatic dysfunction, myocarditis and pulmonary 
haemorrhage. 
In Liver, damage is at subcellular level. An endotoxin like 
substance in the wall of spirochetes has been suggested. Plasma 
TNF-α level related to severity of organ involvement. Liver necrosis 
is minimal and focal. Zone 3 necrosis absent. Active hepatocellular 
regeneration, is out of proportion to cell damage. Cirrhosis is not a 
sequalae. 
Examination of kidney from autopsy reveals ischemic damage 
including epithelial cell necrosis in the DCT and ascending loop of 
henle and interstitial nephritis but only rarely glomerular damage. 
According to C.W. Yang et al33, Leptospira outer membrane proteins 
(OMPs) may elicit tubular injury and inflammation through Toll- 
like receptor (TLR) dependent pathway followed by activation of 
nuclear transcription factor Kappa B and mitogen activated protein 
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kinases and a differential induction of chemokines and cytokines 
relevant to tubular inflammation. 
CLINICAL FEATURES: 
Symptoms usually develop 7-12 days after exposure. Clinical 
presentation of leptospirosis is biphasic with an acute or septicemic 
phase lasting about a week, followed by the immune phase 
characterised by antibody production and excretion of leptospires in 
the urine. Most of the complications occur during immune phase and 
thus occur during the second week of illness. 
ANICTERIC LEPTOSPIROSIS: 
Great majority are subclinical. Patients usually have symptoms 
like chills, headache, myalgia, abdominal pain and conjunctival 
suffusion. Myalgia affecting lower back, thighs and calves is often 
intense. This last few about a week and its resolution coincides with 
the appearance of antibodies. 
ICTERIC LEPTOSPIROSIS: 
More severe disease, rapidly progressing. 5-10% of patients of 
leptospirosis enter into icteric phase. Mortality rate is about 5-15% 
liver function test return to normal after recovery. Serum bilirubin 
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may be high, moderate rise of transaminase level and minor 
elevation of alkaline phosphatase level usually occurs 
                               Figure - 3 
 
Biphasic nature of Leptospirosis and relevant investigations at 
different stages of disease. 
Comparison of symptoms/signs of severe Leptospirosis / Viral 
Hepatitis: 
Table - 2 
 Weils Disease Viral Hepatitis 
Onset Sudden Gradual 
Headache Constant Occasional 
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Muscle pain Severe Mild 
Conjunctival Suffusion + – 
Disorientation Common Rare 
Bleeding + – 
Nausea/Vomiting + + 
Abdominal Discomfort + + 
Albuminuria + – 
Leucocyte Count Polymorph 
leucocytosis 
Leucopenia with 
lymphocytosis 
CPK Increased Normal 
DIAGNOSIS: 
Microscopic Examination: 
Leptospires may be visualised in clinical materials by dark 
field microscopy or by immunofluorescence or light microscopy 
after appropriate staining. Approximately 10-Leptospires/ml are 
necessary for one cell per field to be visible by dark field 
microscopy. 
Dark field microscopy examination of body fluids such as 
blood, urine, CSF and dialysate fluid has been used, but is both 
insensitive and lacks specificity. 
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A variety of histopathological stains have been applied to the 
detection of Leptospires in tissues. Leptospires were first visualized 
by Silver staining and the Warthin-Starry stain is widely used for 
histological examination. Recently, immuno-histochemical methods 
have been applied. 
CULTURE: 
Leptospiremia occurs during the first stage of the disease, 
beginning before the onset of symptoms and ends by first week of 
the illness. Therefore blood cultures should be taken as soon as 
possible after the patient presentation. 
One or two drops of blood are inoculated into 10ml of 
semisolid medium containing 5-flurouracil at the patients bedside. 
Apart from blood, CSF and dialysate fluid can also be cultured 
during first week of illness. Urine can be cultured from the 
beginning of the second week of symptomatic illness. 
Cultures are incubated at 28 to 30oC and examined weekly by 
dark field microscopy for upto 13 weeks before being discarded. 
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ANTIGEN DETECTION: 
Detection of Leptospiral antigens in clinical material offer 
greater specificity than DFM. Radio immunoassay (RIA) can detect 
104 to 105 sub Leptospires/ml and enzyme-linked immunosorbent 
assay (ELISA) can detect 105 sub Leptospires/ml. 
ANTIBODY DETECTION: 
Antibodies can become detectable by the 6th to 10th day of 
disease and generally reach peak levels with 3 to 4 weeks. Antibody 
level then gradually recede but may remain detectable for years. 
Serological methods can be divided into two groups: those, which 
are genus specific and those which are serogroup specific. 
Microscopic Agglutination Test (MAT): 
The reference method for serological diagnosis of leptospirosis 
is the MAT, in which patient sera are reacted with live antigen 
suspensions of Leptospiral serorars. After incubation, the serum 
antigen mixtures are examined microscopically for agglutination and 
the titres are determined. The MAT is read by Dark field 
microscopy. The end point is the highest dilution of serum at which 
50% agglutination occur. 
Paired sera are required to confirm a diagnosis with certainly. 
A fourfold or greater rise in titre between paired sera confirms the 
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diagnosis regardless of the interval between samples. If symptoms of 
overt Leptospirosis are present, an interval of 3 to 5 days may be 
adequate to detect rising titres. However, if the patient present 
earlier in the course of the disease or if the date of onset is not 
known precisely, then an interval of 10 to 14 days between samples 
is more appropriate. 
In the current CDC case definition1, a titre of >200 is used to 
define a probable case with a clinically compatible illness. In areas 
where Leptospirosis is endemic, a single titre of >800 in 
symptomatic patients is indicative of Leptospirosis. The National 
Institute of Communicable diseases2 (NICD), New Delhi case 
definition also advocates a MAT titre of >200. 
Other Serological Tests: 
Because of the complexity of the MAT, rapid screening tests 
for Leptospiral antibodies in acute infection have been developed. 
Complement fixation (CF) was widely used but methods were not 
standardized. CF tests have generally been replaced by ELISA 
method. 
IgM detection has repeatedly been shown to be more sensitive 
than MAT when the first specimen is taken early in the acute phase 
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of the illness. The drawback of this test is that the infective serovars 
cannot be assessed. Though this test is more sensitive than MAT, it 
is less specific. 
TREATMENT: 
Antibiotic treatment is most beneficial if started within 4 days 
of illness. Unfortunately, the diagnosis of Leptospirosis is rarely 
made this rapidly. 
Treatment and chemoprophylaxis of Leptospirosis41 
Table - 3 
Treatment of Drugs 
Mild Leptospirosis Doxycycline 100mg orally bd (or) Amoxycillin 
500mg orally tid 
Moderate / Severe 
leptospirosis 
Penicillin G, 1.5 million units IV qid (or) 
Ampicillin 1g IV tid (or) 
Ceftriaxone 1g IV od (or) 
Cefataxime 1g IV tid 
Chemoprophylaxis Doxycycline 200mg orally once a week 
Note: All regimens used for treatment are administered for 7 days. 
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MALARIA 
HISTORY: 
Hippocrates called as 1st Malariologist. By 400 BC, he 
describe various Malarial fever of man. Galen29, ancient Greek 
physician noticed first jaundice among malaria infected people. 
Charles Louis Alphonsa Laveran, French physician identified 
malarial parasite in 1888. 
William G. McCallum29 in 1897, demonstrate sexual process 
of malarial parasite. Ronald Ross identified infected female 
anaphiline mosquito responsible for transmission. 
DIAGNOSIS: 
Peripheral smear examination is the corner stone for diagnosis 
of malaria. Two type of peripheral smear examined thick smear and 
thin smear. In thick smear, dried for 30 minutes and not fixed with 
methanol. Allow RBC and leukocytes to haemolyse and any malarial 
parasite present will be the only detectable element. It is used to 
detect infection and to estimate parasite concentration. 
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In thin smear, air dry for 10 minutes, fixed with methanol 
(dipping the slide into methanol for 5 seconds) used for specification 
of parasites and sensitivity of thin film is 200 parasites/µl of blood. 
QBC Malarial Method: 
It was developed by Becton and Dickenson29. It is positive for 
Malaria, Babesiosis, Tryponosomiasis, Filariasis and relapsing fever. 
METHOD: 
QBC tube is a high precision glass hematocrit tube, precoated 
internally with acridine orange stain and potassium oxalate. QBC 
tube has to fill with 55 to 65 µl of blood. Tube centrifuged at 12,000 
rpm for 5 minutes. Component of buffy coat separated bands. QBC 
tube is placed on tube holder and examined using a standard white 
light microscope equipped with the UV microscope adaptor. 
Fluorescing parasites are then observed at the red blood cell/WBC 
interface. 
Since the parasite contain DNA which take up acridine orange 
stain, they appear as bright speaks of light among the non-
fluorescing red cells. Virtually all the parasite found in 60ml of 
blood can be visualised by rotating the tube under microscope. 
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 Peripheral Smear QBC Method 
Method Cumbersome Easy 
Time Longer 60-120min Faster 15-30 min 
Sensitivity 5 parasite/µl of 
thick film. 
200 parasite/µl of 
thin film 
Claim to be more sensitive at 
least as good as thick film. 
Specificity Gold standard ? False +ve  
Species 
identification 
Gold standard Not 
Cost Inexpensive Costly 
RAPID DIAGNOSIS OF MALARIA: 
Immunochromatographic test for Malarial Antigen: 
Based on capture of parasite antigen from the peripheral blood 
using either monoclonal (or) polyclonal antibodies against the 
parasite antigen target. 
a) Histidine rich protein 2 of plasmodium falciparum 
Water soluble protein produced by asexual stage and 
gametocyte of P.falciparum, expressed on red cell membrane 
surface. Remains in the blood for 28 days after the initiation of 
antimalarial therapy. 
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b) Plasmodium Aldolase: 
Enzyme of parasite glycolytic pathway expressed by blood 
stages of P.falciparum as well as non-falciparum malaria. 
c) Parasite lactate dehydrogenases: 
Soluble glycolytic enzyme produced by asexual and sexual 
stages of live parasite found in all 4 species of malaria. 
MALARIAL HEPATHOPATHY 
Jaundice23 present in 2.5% of patients with malaria. According 
to WHO, there is increase number of report favouring existence of 
malarial hepatopathy from Asian countries especially from India. 
Severe haemolysis and rupture of hepatocytes during primary 
schizogony are responsible for jaundice in malaria. Here there is 
usually only mild elevation of liver enzymes. 
Malarial hepatitis characterised by rise in serum bilirubin 
along with rise in transaminases more than three times the upper 
limit of normal. 
Histological hallmark of malarial hepatopathy is presence of 
acute injury to hepatocytes and deposition of malarial pigment. 
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Study conducted by Murthy et al24 shows 21% of patients 
with falciparum malaria has malarial hepatitis. 
ACUTE VIRAL HEPATITIS 
Acute viral hepatitis is characterised by constitutional 
symptoms like anorexia, nausea/vomiting, arthralgia, myalgia, 
headache, cough etc., may precede the onset of jaundice by 1-2 
weeks with the onset of jaundice, the constitutional prodromal 
symptoms usually diminish. Liver become enlarged and tender. 
Splenomegaly and lymphadenopathy present in 10-15% of patients. 
During the recovery phase, constitutional symptoms disappear. 
Some liver enlargement and abnormal biochemical values still 
persist. Duration of post icteric phase variable ranging from  2-12 wks. 
Serum aminotransferase increase during the prodromal period 
itself and precede the rise in bilirubin level. Prolonged prothrombin time 
and low albumin level in viral hepatitis indicate worse prognosis. 
All acute viral hepatitis needs only supportive therapy except 
Hepatitis C which need peglylated interferon α and Ribavarin for 48 
weeks. 
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TYPHOID HEPATITIS 
Hepatitic complications of typhoid fever first reported by 
William Osler31 in 1899. Salmonella organisms31 are phagocytosed 
by reticuloendothelial system by overcome the cell’s killing action 
and produce hepatic injury and liberate toxin. 
Liver biopsy shows focal Kupffer cell hyperplasia and 
mononuclear cell infiltration of the portal space. 
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MATERIALS AND METHODS 
SELECTION CRITERIA: 
• Patients with acute onset of fever and jaundice of less than 20 
days duration were included in the study. 
• All patients were >12 years of age. 
EXCLUSION CRITERIA: 
• Patients with chronic liver disease were excluded from this 
study. 
• All pediatric cases were excluded from this study. 
• All retroviral diseases were excluded from this study. 
No. of patients studied: 142. 
Period of study: Between January 2008 to October 2008. 
Study Design: Prospective Study 
Ethical Clearance: Obtained. 
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METHODS: 
All patients admitted in Govt. General Hospital, Chennai with 
fever and jaundice were evaluated. Consent for study obtained. 
Detailed history was taken regarding duration of fever and jaundice,  
occupation and immunisation against Hepatitis A and Hepatitis B 
viruses. Thorough clinical examination was done in all cases. 
Documentation was done using a stratified proforma which 
included symptoms like Jaundice, Fever, Headache, Myalgia, 
vomiting, chills & rigor, conjunctival suffusion, Bleeding 
manifestation, abdominal pain, diarrhea, oliguria, cough & burning 
micturitun. 
Signs like icterus, rashes, signs of dehydration, anaemia, 
splenomegaly, hepatomegaly, lymphadenopathy, muscle tenderness, 
pedal edema, altered sensorium, and signs of meningeal irritations 
were noted.  
Investigations like complete haemogram, renal function test 
and liver function test on every 3rd day, urine routine,  12 lead ECG, 
x-ray chest, ultrasonogram of abdomen, smear for Malarial parasite, 
widal test, macroscopic slide agglutination test (MSAT) and 
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microscopic agglutination test (MAT) for Leptospirosis, viral 
markers like IgM Anti-HAV antibody, HbsAg and anti HCV, and 
blood-culture and sensitivity were done on all patients. 
If the patients has acute renal failure, renal function test was 
done daily. 
Follow up of all patients regarding treatment and outcome 
were done during the hospital stay. 
Eye manifestations of Leptospirosis done with detailed history 
and fundus examination. 
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RESULTS 
Number of cases admitted with fever and jaundice: 142 
Number of male cases  : 91 (64%) 
Number of female cases : 51 (36%) 
Age and Sex Distribution:  
Table 4 
Number of patients 
Age 
Male (%) Female (%) 
12-20 years 11 (7.7%) 5 (3.5%) 
21-30 years 17 (11.9%) 13 (9.1%) 
31-40 years 31 (21.8%) 16 (11.2%) 
41-50 years 19 (13.3%) 9 (6.3%) 
>50 years 13 (9.1%) 8 (5.6%) 
Etiological Agent:  
Table 5 
Agent Number of patients n=142 Percentage 
Leptospirosis 50 35.2% 
Malaria 24 16.9% 
Viral Hepatitis 19 13.3% 
Gall bladder disease 3 2.1% 
Unknown 46 32.3% 
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ANALYSIS OF LEPTOSPIROSIS POSITIVE CASES 
A Leptospirosis positive case is one with a MAT titre of more 
than 1:200 among patients presenting with fever and jaundice - as 
per CDC1 case definition 1997 and National Institute of 
Communicable Diseases2 - NICD case definition 2001. 
Number of cases found serologically positive for leptospirosis: 50. 
One patient positive for both Leptospirosis and Hepatitis A. 
Age Distribution:  
Table  6 
Age Number of patients n=50 Percentage 
12-20 years 9 18% 
21-30 years 9 18% 
31-40 years 15 30% 
41-50 years 10 20% 
>50 years 7 14% 
Sex Distribution: 
Number of male cases  : 33 (66%) 
Number of female cases : 17 (34%) 
  
35
Distribution of signs and symptoms:  
Table 6 
Symptoms/Signs Number of patients n=50 Percentage 
Fever 50 100% 
Jaundice 50 100% 
Headache 31 62% 
Myalgia 47 94% 
Chills/rigor 13 26% 
Nausea/Vomiting 20 40% 
Cough 18 36% 
Conjunctival Suffusion 38 76% 
Abdominal pain 10 20% 
Diarrhea 12 24% 
Oliguria 8 16% 
Skin rash 2 4% 
Dehydration 12 24% 
Pallor 13 26% 
Pedal Edema 10 20% 
Lymphadenopathy 1 2% 
Hepatomegaly 10 20% 
Splenomegaly 4 8% 
Muscle tenderness 20 40% 
Altered sensorium 15 30% 
Meningeal sign 0 0% 
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Average duration of fever on presentation is 9.6 days. 
Average duration of jaundice on presentation is 4.8 days. 
Ocular manifestations:  
Table  7 
Signs Number of patients 
n=50 Percentage 
Conjunctival Hyperemia 38 76% 
Subconjunctival Haemorrhage 3 6% 
Fundus abnormality 0 0% 
Occupation:   
Table 8 
Occupation Number of patients 
n=50 Percentage 
Manual workers 30 60% 
Non-Manual workers 8 16% 
Students 4 8% 
Others 8 16% 
ANALYSIS OF LABORATORY INVESTIGATIONS OF 
LEPTOSPORISIS CASES 
COMPLETE HEMOGRAM: 
Hemoglobin: 
• The mean Hemoglobin values was 10.5gm%. 
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• Range 7.1 - 14.0 gm% 
• 3 patients had Hb% <8 gm% 
WBC Count: 
• The mean total WBC count was 6500 cells/µl 
• Range 4100-12000 cells/µl. 
Platelet Count: 
• The mean platelet count was 1.67 lakhs/µl. 
• Range 31,000-3,33,000/µl. 
• Six patients had platelet count <1 lakh/µl. 
Erythrocyte sedimentation rate: 
• The mean ESR at 1 hr was 26mm. 
• Range 6-120mm. 
LIVER FUNCTION TESTS: 
Total bilirubin:   
Table 9 
Total Bilirubin (mg/dl) Number of patients 
n=50 Percentage 
2.1 – 5 19 38% 
5.1 – 10 17 34% 
10.1 – 15 11 22% 
>15 3 6% 
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Table 10 
On Admission mean Range 
Total bilirubin 7.8mg/dl 2.1 - 38 
Indirect bilirubin 3.3mg/dl 0.4 - 10.1 
Direct bilirubin 4.7mg/dl 1.1 - 28 
SGOT (U/L) 74.6 U/L 35-240 
SGPT (U/L) 75.08 U/L 26-300 
Alkaline phosphatase (gm/dl) 133.14g/dl 64-240 
Renal function test:   
Table 11 
Test Mean Range 
Blood Urea (mg/dl) 56.72 24-180 
Sr. Creatinine (mg/dl) 1.73 0.6-8 
Blood Urea levels:  
Table 12 
Urea (mg/dl) Number of patients n=50 Percentage 
<40 30 60% 
40-80 11 22% 
80-120 5 10% 
>120 4 8% 
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Sr. Creatinine Levels:   
Table 13 
Sr.Creatinine (mg/dl) Number of patients n=50 Percentage 
<1.2 31 62% 
1.2 - 3.0 10 20% 
3.0  - 5.0 6 12% 
>5.0  3 6% 
Serovars Analysis:   
Table 14 
Serovars Number of patients n=50 Percentage 
Icterohemorrhagiae 20 40% 
Semaranga 16 32% 
Grippotyphosa 6 12% 
Automnalis 5 10% 
Australis 3 6% 
Serovars and Complication correlations:   
Table 15 
Serovars Number of patients n=21 (%) 
Renal failure  
n=19 (%) 
Icterohemorrhagiae 10 (47%) 14 (74%) 
Semaranga 4 (19%) – 
Grippotyphosa 3 (14%) 2 (10.5%) 
Automnalis 3 (14%) 2 (10.5%) 
Australis 1 (4%) 1 (5%) 
  
40
After rehydration, renal function test returns to normal in 10 
patients. 
Outcome: 
Total number of Leptospirosis positive cases: 50 
Number of cases expired : 5 
Mortality rate   : 10% 
ANALYSIS OF MALARIA POSITIVE CASES 
Number of cases positive for malaria in patients  
presented with fever and jaundice   : 24 
Number of Plasmodium falciparum cases  : 17 
Number of Plasmodium vivax cases   :  7 
SYMPTOMS AND SIGNS OF MALARIAL CASES: 
Table 16 
Symptoms/Signs Number of patients n=24 Percentage 
Headache 21 87.5% 
Chills/rigor 22 91.6% 
Nausea/Vomiting 11 45.8% 
Myalgia 4 16.7% 
Conjunctival Suffusion 2 8.3% 
Oliguria 4 16.7% 
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Symptoms/Signs Number of patients n=24 Percentage 
Pallor 12 50% 
Splenomegaly 9 37.5% 
Altered sensorium 10 41.7% 
Complication of malaria:  
Table 17 
Complications Number of patients n=24 Percentage 
Anaemia 16 66.7% 
Thrombocytopenia 12 50% 
Malarial Hepatopathy 4 16.7% 
Renal Failure 7 29.2% 
Hepatitis virus marker pattern:  
Table 18 
Hepatitis Virus Number of patients n=19 Percentage 
Hepatitis A 4 21% 
Hepatitis B 10 52.6% 
Hepatitis C 5 26.3% 
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DISCUSSION 
Among the patients present with history of short duration of 
fever and jaundice, in our study Leptospirosis constitute about 
16.9%  Malaria 16.9% and Viral hepatitis 13.3%. 
Study conducted in Thanjavur Medical College8 in 2006, 
which was non-endemic area for Leptospirosis, shows Leptospiral 
positivity rate of 24%. Also study conducted in puduchery8 shows 
Leptospirosis in 12% of cases of fever with jaundice. 
Our study shows Leptospirosis in .35.2%. Therefore 
Leptospirosis is most common cause of patients present with short 
duration of fever and jaundice in chennai and the incidence of 
Leptospirosis also very high among these patients when compared to 
other studies. 
Study conducted in Department of Medicine, Lady Hardinge 
Medical College Hospital, New Delhi in 2000, among patients 
presented with acute liver failure28 (fever and jaundice) shows Viral 
hepatitis 52.7%, Malaria 19.4% and Leptospirosis 16.7%. 
Also study conducted by Department of Paediatric, KEM 
hospital35, Mumbai, shows Viral hepatitis 61%, Another study 
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conducted in Rajahmundry town of Andhrapradesh20 during 1997-
1998 during jaundice epidemic shows Viral hepatitis 45.8%. 
WHO bulletin, 200012 shows that in India, Seropositivity rate 
for Leptospirosis vary from place to place. 
South India : 25.6% 
North India : 8.3% 
West India : 3.5% 
East India : 3.1% 
This clearly shows that Leptospirosis is more prevalent in 
South India. 
All studies20,21,26 conducted in North India shows that viral 
hepatitis constitute major etiology among patients presented with 
fever and Jaundice. But in our study, Leptospirosis constitute major 
etiology. This change of pattern is due to high seroprevalence of 
Leptospirosis in South India. 
Also algorithm for management of short duration of fever and 
jaundice has to programmed according to local prevalence of 
etiological agent and age pattern. 
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ALGORITHM 
Fever with Jaundice 
History / Physical Examination 
Liver Function Test 
 
 
Isolated Elevation of  
Bilirubin 
Total bilirubin and Enzymes 
elevated 
 
Malaria  
Druginduced 
haemolysis 
Mild  
Transaminitis 
Hepatocellular 
pattern 
(AST/ALT out 
of Proportion  
to ALP) 
Cholestatic 
Pattern (ALP 
out of 
Proportion to 
AST/ALT) 
 
Peripheral smear 
(or) QBC test 
Leptospirosis 
  
 
<7 Days  >7 Days 
 
Blood Culture  
PCR 
 
MSAT MAT 
Dipstick Test 
 
 
 
   ALT > AST    ALT < AST   Malarial Hepatopathy 
              Typhoid Hepatitis 
 
Viral Hepatitis  Alcoholic Hepatitis   Liver Biopsy 
IgM - HAV, HbsAg, Anti HCV 
Igm - HAV Positive Hbs Ag Positive Anti HCV Positive 
Acute Hepatitis A     Igm anti HBc       Hepatitis C 
  Acute Hepatitis B  Chronic Hepatitis B 
     Ultra Sound       
GB Disease      Hepatitis A 
       CMV EBV 
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ANALYSIS OF LEPTOSPIROSIS POSITIVE CASES 
Of 142 patients analysed for short duration fever and jaundice, 
50 patients have Leptospirosis positive. 
Males are predominantly affected due to outdoor work in the 
field. Mostly 30-40 years of age is predominantly affected. 
Manual workers in the field occupied maximum of 60%. 
COMPARING OCCUPATION PATTERN 
Table 19 
Occupation GGH, Chennai 1990
8 
n=57 
Present Study 
n=50 
Manual Worker 57.8% 60% 
Non-Manual 
worker 
22.8% 16% 
Others 19.4% 24% 
COMPARING MONTHLY INCIDENCE OF 
LEPTOSPIROSIS 
Table 20 
 Jan Feb March July Sep Oct Nov 
GGH, Chennai8 
1987-93 
5 1 – 1 4 65 100 
Present Study 1 – 4 3 16 10 – 
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Both studies show sharp raise in incidence of Leptospirosis 
after monsoon months like September and October. 
Symptoms that are more common for Leptospirosis like 
Myalgia and Conjunctival suffusion constitute 92% and 76% 
respectively. 
Other symptoms found in high percentages are headache 62%, 
Nausea/vomiting 40%, cough 36%, abdominal pain 20%, Diarrhea 
24% and Oliguria 16%. 
Sign analysis shows muscle tenderness in 40%, Altered 
sensorium 30%, pallor 26%, Pedal edema 20%, Hepatomegaly 20% 
and splenomegaly 8%. 
Comparison of sings and symptoms on admission in patients with 
Leptospirosis in large series and in this study: 
Table 21 
Signs and  
symptoms 
China36 
1965 n=168 
India36 
1992 n=57 
Brazil36 
1999 n=193 
Present 
study n=50 
Jaundice 0 84 95 100 
Headache 90 26 92 62 
Conjunctival 
suffusion 
57 58 35 76 
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Signs and  
symptoms 
China36 
1965 n=168 
India36 
1992 n=57 
Brazil36 
1999 n=193 
Present 
study n=50 
Vomiting 18 58 – 40 
Myalgia 64 82 94 94 
Abdominal pain 26 18 – 20 
Dehydration – 39 – 24 
Cough 57 32 – 36 
Diarrhea 20 26 – 24 
Hepatomegaly 28 – – 20 
Lymphadenopathy 49 – – 2 
Skin rash – – – 4 
Meningeal sign – 7 – 0 
Altered sensorium – 42 – 30 
In ocular manifestation of Leptospirosis, conjunctival 
hyperemia in 76% sub conjunctival haemorrhage 6% and no fundus 
abnormality. All patients with subconjunctival haemorrhage have 
low platelet. One patient also positive for IgM - Dengue antibody. 
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Ocular manifestation in comparison with large series: 
Table 22 
 
MG. Martin25 et 
al 
Hetal25 et 
al 
Present 
study 
Conjunctival Hyperemia 86% 76% 76% 
Subconjunctival 
Haemorrhage 
19% 25% 6% 
Fundus changes 48% 15% 0% 
Our study has low incidence of subconjunctival haemorrhage 
and fundus changes. This is because of change in pattern of serovars. 
Fundus changes more commonly documented on these studies was 
retinal haemorrhage. In our study, over all bleeding manifestation is 
reduced compared to other large series studies. 
ANALYSIS OF LABORATORY INVESTIGATIONS 
Complete Haemogram: 
Complete haemogram revealed that most patients had 
haemoglobin level more than 10gm%. Only three patients had 
haemoglobin level less than 8gm%. Anaemia may be due to 
obscured bleeding. 
The total count of WBC revealed mild leucocytosis in three cases. 
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Most of them had normal platelet count, except for six patients 
who had platelet count less than 1 Lkh/µn. Most of these patients 
had bleeding manifestations. 
There was a mild rise in erythrocyte sedimentation rate in most 
of the patients. One of the patients had ESR above 100mm in 1 hour. 
It is evident from these observations that non-specific changes 
in haemogram can occur in leptospirosis. Though they are not useful 
in the diagnosis of disease, they are helpful in suspicion of the disease. 
LIVER FUNCTION TEST: 
The analysis of LFT reveals a high level of bilirubin on 
admission ranging from 2.1 to 38 mg/dl. There was a conjugated 
hyperbilirubinemia in most of the cases. 
There was mild increase in serum transaminase level while 
there was a moderate increase in serum alkaline phosphatase levels. 
The total protein level was within normal limits. Further follow-up 
of the patients during the hospital stay revealed that the enzyme 
levels returned to normal on treatment. 
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RENAL FUNCTION TEST: 
While only eight patients presented with oliguria, laboratory 
investigations revealed mild to severe elevation of blood urea and 
serum Creatinine level in 38% of patients. After hydration, in ten 
patients, renal function returned to normal. Nine patients taken for 
haemodialysis by nephrologists and three of them expired. 
Biochemical values compared with study conducted in Chennai. 
Table 23 
Parameters Abnormal Values Muthusethupathi
7
 
et al n=57 
Present Study 
n=50 
Bl. Urea >40mg/dl 72% 40% 
Sr. Creatinine >1.2mmg/dl 72% 38% 
Total bilirubin >2mg/dl 82% 100% 
SGOT >40mg/dl 44% 78% 
SGPT >40mg/dl 47% 78% 
Platelets >1Lakh/µl 23% 12% 
Muthusethupathi7 et al study include only fever cases positive 
for Leptospirosis but present study patients present with fever and 
jaundice, positive for Leptospirosis. Therefore total bilirubin and 
liver enzymes are in high level compared to previous study. Over all 
complication rate of Leptospirosis is in decline. 
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Most common serovars in our study was Icterohaemorrhagiae 
(40%), semaranga 32%, Grippotyphosa 12% etc. 
Serovars Semarange belongs to non-pathogenic serovars and in 
our study it occupied 32%. This may be because in our microbiology 
laboratory, they named unidentified species as serovar semaranga. 
This may be reason why semaranga serovars produce complications 
in our study. 
Study conducted in Andaman island by Sameer Sharma et al39 
about serovars prevalence among high risk group shows serovars 
Grippotyphosa and Australis as Commonest serovars. 
Another study conducted near Madras city following an 
outbreak of the disease in cattle shows automnalis antigen 62% 
(Ratnam et al40) 
Complications like thrombocytopenia and renal failure is more 
common with icterohaemorrhagea in Chennai. 
All the patients diagnosed to have Leptospirosis started on 
intravenous Benzyl Penicillin for a period of 10 days. 
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This study also reveal a mortality rate of complicated icteric 
Leptospirosis as 10%. Levett PN36 gives the mortality rate as 5-
15%. 
Comparative analysis of leptospirosis/Malaria/Viral Hepatitis: 
Table 24 
Disease Incidence Common Symptoms 
Liver function test 
pattern Complication 
Mortality 
Rate 
Leptospirosis 35.2% Myalgia 
(94%) 
Conjunctival 
suffusion 
(76%) 
Conjugated 
hyperbilirubinemia 
Minimal 
transaminase 
elevation 
Thrombocytopenia 
(42%) 
Renal failure 
(38%) 
10% 
Malaria 16.9% Chills/ 
Rigor (92%) 
Headache 
(87%) 
Unconjugated 
hyperbilirubinemia 
Mild elevation of 
liver enzymes 
Anaemia (66.9%) 
Thrombo-
cytopenia (50%) 
8% 
Viral 
hepatitis 
13.3% Nausea 
vomiting 
(79%) 
Myalgia 
(47%) 
Conjugated 
hyperbilirubinemia 
Very high 
enzymes level 
AST > ALT 
Anaemia (57.8%) 5% 
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ANALYSIS OF MALARIA POSITIVE CASES 
Among the 142 cases, 24 cases are positive for malarial 
parasite. Of 24 cases, 17 cases positive for falciparum malaria and 7 
cases positive for vivax malaria. Though vivax malaria is more 
prevalent that falciparum malaria in India, in our study falciparum 
malaria is common because we include only complicated malaria 
(fever with jaundice). Complicated malaria is more common with 
falciparum malaria. 
Symptoms more common in complicated malaria cases like 
Headache and chills/rigor present in 87.5% and 91.6% respectively. 
Compared to other series: 
Table 25 
Symptoms Murthy24 et al Echeverri M30 et al Present Study 
Chills/Rigor 98.1% 91% 91.6% 
Altered 
Sensorium 
48.1% – 47.1% 
Headache – 91% 87.5% 
Oliguria 7% – 16.7% 
Anaemia 75% 46% 66.7% 
Thrombo 
cytopenia 
40% 8% 50% 
Renal failure 25% – 29.2% 
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Murthy et al24 study include mostly falciparum malaria like 
our study but Echeverri M et al30 study conducted in Columbia and 
include mostly vivax malaria. 
Also study conducted by Sivakumar et al6 shows malarial 
ARF 10%, Leptospiral ARF 45%. 
In our study, Malarial hepatopathy documented in 16.7%. In 
Murthy et al24 study, Malarial hepatopathy constitute 21%. 
In this study among the viral hepatitis19 cases, 21% due to 
Hepatitis A4 ,52.6% due to hepatitis B10 and 26.3% due to hepatitis 
C.. Viral hepatitis pattern in Rajamundry town of Andhrapradesh28, 
Hepatitis A 13%, Hepatitis B 28%, Hepatitis C 2.1%, Hepatitis D 
13%, and Hepatitis E 42.1%. 
In other series 
Table 26 
Viral Markers Khanna et al20 R.Kaur et al21 Present study 
Anti IgM HAV 9% 2.3% 21% 
Hbs Ag 16% 12.7% 52.6% 
Anti HCV 2% 3.3% 26.3% 
Anti HEV 67% 20.6% – 
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Analysis of viral markers pattern in North India 20,21,27 shows 
that hepatitis E prevalence in on increase. One of the important 
limitations of our study is we have not done Ig M anti HEV, due to 
non availability in our institute. Therefore viral marker pattern can 
not be compared with longer series due to lack of Ig M anti HEV. 
Of the 142 patients included in our study only one patient was 
immunised against hepatitis B. In 1991, WHO ordered inclusion of 
Hepatitis B vaccine in National immunization program in high 
endemic countries by 1995 and in all countries by 1997. In 2001, 
WHO set new goal of 90% coverage with 3 doses regimen of 
Hepatitis B Vaccine for all children by 2015. 
LIMITATIONS OF THIS STUDY: 
1) Since we have small sample size, individual disease and 
parameter comparison with large series may produce 
Type II error. 
2) In our microbiology laboratory, they named every 
unidentified serovars as semaranga. This will falsely 
report more semaranga serovars. 
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3) We haven’t done IgM - anti HEV for diagnosis of 
Hepatitis E. due to non availability in our institute. So 
we can’t compared with large series Hepatitis viral 
marker pattern. 
4) We have not demonstrated four fold rise in MAT titre 
for diagnosis of Leptospirosis due to limited resource in 
our institution. 
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CONCLUSION 
1) Among patients present with short duration of fever and 
jaundice, have etiological agents, in decreasing order of 
frequency as Leptospirosis 35.2%, Malaria 16.9% and 
Viral hepatitis 13.3%. 
2) Most of the cases of Leptospirosis are from North 
Madras, during the monsoon months like September, 
October and among manual workers (60%). 
3) Apart from fever and jaundice, the most common 
symptoms/signs in patients with Leptospirosis are 
Myalgia, Headache and conjunctival suffusion. Malaria 
are chills/rigor, Headache and viral hepatitis are nausea/ 
vomiting or myalgia. 
4) The Leptospirosis and Viral hepatitis cases have 
conjugated hyperbilirubinemia whereas malarial cases 
have unconjugated hyperbilirubinemia. 
5) All patients positive for Leptospirosis responded well to 
intravenous Benzyl penicillin. 
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6) Nine cases went into intrinsic acute renal failure, taken 
for haemodialysis and three of them expired. 
7) Most common serovars in our study was icterohaemorrhagea. 
8) Virulance of icterohaemorrhagea is on decreasing trend, 
compared to previous study. 
9) The over all mortality of icteric Leptospirosis cases was 
10%, Malarial case 8% and Viral hepatitis 5%. 
10) Malarial hepatopathy and renal failure associated with 
16.7% and 29.2% of malaria positive cases. 
11) Among the acute viral hepatitis, Hepatitis B constitute 
most common causes among adults. 
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KEY TO MASTER CHART 
NMW -  Non Manual Worker 
MW - Manual Worker 
S - Student 
O - Others (Retired, House wife etc.,) 
N - Normal 
PV - Plasmodium Vivax Malaria 
PF - Plasmodium Falciparum  Malaria 
Ictero - Icterohaemorrahagea 
+ - Positive 
- - Negative 
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present with fever and Jaundice and to Analyse 
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                             PROFORMA 
Name :                                                                            Ip. No : 
Age :                                                                               DOA : 
Sex :                                                                                 DOD : 
Address : 
 
Occupation : Manual / Non Manual worker / Other 
Immunisation : 
Symptoms :  (At admission) 
 
Jaundice : ................ days                                     Conjunctival suffusion : 
Fever : .................days                                           Bleeding manifestation : 
Head Ache : 
Myalgia :                                                                   Abdominal pain : 
Chills & Rigor :                                                          Diarrhea : 
Nausea / vomiting :                                                Oliguria : 
Cough :                                                                      Burning Micturition : 
Others : 
 
Signs : (At admission ) 
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Skin Rash :                                                               Splenomegaly : 
Hydration :                                                              Muscle Tenderness : 
Pallor :                                                                     Altered sensorium : 
Pedal edema :                                                       Meningeal signs : 
Lymphadenopathy :                                             Fundus examination: 
Hepatomegaly : 
 
Investigation : 
1. Haemogram :   Hb :.............gm % 
TC :.............Cells/u 
DC : P.....L.....E...... 
Platelet Count :....... 
RBC :..........Cells /Ul 
ESR  ½ hr :.........mm 
1   hr :..........mm 
 
2. 
 
3. Urine : Albumin : 
Sugar : 
Deposit : 
Test Day 1 Rpt.(......day 
) 
Rpt 
(.......day) 
Bl. Sugar (mg/dl )    
Bl. Urea (mg/dl)    
Sr. 
Creatinine(mEq/l) 
   
Sr. Na+(mEq/l)    
Sr . K+(mEq/l)    
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Bile salt : 
Bile pigment : 
 
4. Liver Function Test : 
Test Day  1 Rpt (.......day) Rpt (.......day) 
Total bilirubin 
(mg/ dl) 
   
Direct 
Bilirubin(mg/dl) 
   
Indirect 
bilirubin(mg/dl) 
   
SGOT (U/L)    
SGPT (U/L)    
Sr. Alkaline 
phosphatise(Iu/l) 
   
Total protein 
(g/dl) 
   
 
 
5. X- ray Chest  PA  View : 
6. ECG : 
7. USG . abd & pelvis : 
8. Mp/Mf : 
9. WIDAL : 
10. Blood Culture & sensitivity : 
   11. MSAT : 
   12. MAT : 
   13.IgM anti HAV   
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  14.  Sr. HbsAg: 
 15.Anti-HCV 
                 
 
   Treatment given : 
       
 
 
 
 
 
 Outcome             
                              Cured                              Death                                                     
 
  
 
 
 
 
 
 
  
 
 
 
 
  
 
  
 
 
 
 
 
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Sl. No Name Hb (gl) TC (Cell) Platted ESR (1Hr) TB DB Indirect SGOT (U/L)
75 Nithya 12.90 4800 1.90 22.00 25.00 1.50 1.00 5240
76 Siva 11.40 8500 3.17 18.00 10.00 7.00 3.00 229
77 Raja Prasad 10.00 5800 2.10 20.00 8.00 6.20 1.80 512
78 Ravi 10.30 5800 1.60 32.00 1.80 1.20 0.60 206
79 Kamalakannan 8.90 13400 1.41 34.00 19.20 11.80 7.40 297
80 Rathan 10.00 7200 2.40 18.00 10.50 7.20 3.30 620
81 Perumal 11.70 7100 1.91 16.00 11.50 7.50 4.00 711
82 Venkatesan 13.10 6300 1.79 22.00 7.10 3.00 4.10 210
83 Ramesh 9.30 7100 1.82 32.00 6.80 4.10 2.70 221
84 Sarulatha 11.00 4800 1.72 20.00 5.80 3.60 2.20 1042
85 Karin 13.00 6400 2.40 18.00 4.00 2.00 2.00 248
86 Sundar 9.90 7200 3.10 28.00 7.20 4.10 3.10 432
87 Sathya Moorthy 12.30 11000 2.70 30.00 9.30 5.60 3.70 291
88 Sulan 11.00 9100 1.92 22.00 8.90 4.90 4.00 329
89 Nalini 10.70 8800 2.70 32.00 6.80 4.20 2.60 323
90 Saravanan 9.90 8100 3.00 20.00 6.70 4.30 2.40 212
91 Jose 10.10 7200 3.20 24.00 7.20 4.00 3.20 411
92 Palani 11.20 7300 1.79 22.00 5.30 4.00 1.30 420
93 Sudha 10.50 7200 3.40 24.00 6.30 4.10 2.20 926
94 Partion 12.10 13000 2.10 42.00 7.10 3.20 3.90 148
95 Mohan 12.70 24000 1.15 18.00 2.40 1.20 1.20 41
96 Pandi 10.00 14600 2.62 32.00 8.70 6.30 2.40 78
SGPT (U/L) ALP BL Urea Sr. Creatinine (Mg/ldr) Smear for MP IM HAV Hb Sag Anti -HCV
3350.00 256.00 28.00 0.90 - + - -
81.00 223.00 19.00 0.70 - + - -
422.00 204.00 25.00 0.80 - - + -
40.00 92.00 18.00 0.70 - - - +
272.00 148.00 22.00 0.80 - - - +
500.00 212.00 34.00 0.90 - - + -
522.00 342.00 30.00 0.80 - - - +
204.00 282.00 30.00 0.70 - - + -
210.00 182.00 26.00 0.90 - - + -
986.00 256.00 32.00 0.80 - + - -
211.00 192.00 25.00 0.60 - + - -
360.00 381.00 32.00 0.70 - - + -
240.00 202.00 29.00 1.00 - - - +
311.00 281.00 24.00 0.60 - - + -
280.00 212.00 26.00 0.70 - - + -
172.00 224.00 32.00 0.90 - - + -
411.00 301.00 40.00 1.00 - - - +
420.00 382.00 30.00 0.70 - - + -
926.00 358.00 42.00 1.10 - - + -
148.00 378.00 26.00 0.70 - - - -
41.00 212.00 37.00 1.10 - - - -
78.00 532.00 28.00 0.90 - - - -
MSAT MAT Ultrasound abdomen Diagnosis Outcome
- - N Hepatitis A Cured
- - Hepatomegaly Hepatitis A Cured
- - Hepatomegaly Hepatitis B Cured
- - Hepatomegaly Hepatitis C Cured
- - Hepatomegaly Hepatitis C Cured
- - N Hepatitis B Cured
- - N Hepatitis C Cured
- - Hepatomegaly Hepatitis B Cured
- - Hepatomegaly Hepatitis B Cured
- - N Hepatitis A Cured
- - N Hepatitis A Cured
- - N Hepatitis B Cured
- - Hepatomegaly Hepatitis C Cured
- - N Hepatitis B Cured
- - Hepatomegaly Hepatitis B Cured
- - N Hepatitis B Cured
- - N Hepatitis C Cured
- - N Hepatitis B Cured
- - Hepatomegaly Hepatitis B Cured
- - Perichulic Fluid GB Disease Expired
- - CBD stone GB Disease Cured
- - CBD stone GB Disease Cured
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1 Krishnaveni 40 M Mugappair 9949 MW 7 3       
2 Saradha 50 F Kanchipuram 23042 MW 12 2          
3 Vengat 38 M Andra 7292 NMW 15 5       
4 Vivek 13 M Kodambakkam 10914 S 8 4       
5 Durai Singh 60 M Mambalam 23192 MW 9 5         
6 Ezhumalai 70 M Vadapalani 47129 MW 11 7     
7 Varadharaj 25 M Arakonam 60181 NMW 13 10      
8 Siranjeevi 21 M Thiruvallur 63838 NMW 12 7        
9 Sarangan 70 M Kanchipuram 74887 NMW 7 2      
10 Suresh Kumar 44 M Perambur 62198 MW 9 4      
11 Jaya 25 F Manali 47282 O 8 3        
12 Batcha 34 M Saidapet 23492 MW 6 2     
13 Nadhan 48 M Kodambakkam 42942 MW 7 1    
14 Stella Mary 29 F Viyasarpadi 42492 O 6 3        
15 Neetu Yadav 55 M Perambur 64948 MW 9 4       
16 Johnson 48 M Koungaiyur 49212 MW 10 5       
17 Naresh 31 M Washermenpet 41911 MW 12 7       
18 Rohitha 49 F Ennore 31590 NMW 12 6     
19 Aswin 40 F Egmore 32913 MW 11 4  
20 Nallasivam 41 M Thiruvetriyur 33579 MW 7 3     
21 Jayalakshmi 53 F Washermenpet 33515 MW 5 2     
22 Vijayanthi 25 F Washermenpet 33695 NMW 8 4    
23 Harish 15 M Kilpauk 33714 S 11 5     
24 Ismail 40 M Tiruvottiyur 33777 MW 10 7    
MASTER CHART
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25 Immanuel 17 M Rayapuram 73668 O 12 8   
26 Kumara Raja 39 M Kilpauk 73659 MW 6 2      
27 Gnanasundari 34 F Washermenpet 64231 MW 9 4       
28 Ayyadurai 44 M Vadapalani 72129 MW 11 5      
29 Asaithambi 17 M Redhills 81211 S 10 7       
30 Sudha 38 F Kodambakkam 51418 MW 12 7      
31 Saritha 27 F Choolai 72698 O 7 2      
32 Leela Rani 47 F Ennore 28555 MW 14 8    
33 Sampath 27 M Royapuram 30938 MW 7 3     
34 Loganathan 40 M Thiruvotriyur 90111 MW 9 4      
35 Arumugam 35 M Egmore 43129 MW 8 4       
36 Kumar 39 M Saidapet 72121 MW 10 5     
37 Thusif 43 M Ennore 94312 NMW 12 7      
38 Rajan 55 M Tondayarpet 74521 MW 7 3      
39 Naveen Kumar 14 M Washermenpet 85241 S 10 4     
40 Priskilla 17 F Porur 74213 O 15 11      
41 Manoj 36 M Royapuram 85942 MW 13 10       
42 Sidharthan 40 M Manali 74211 MW 14 12   
43 Rani 15 F Thiruvotriyur 94223 O 8 4     
44 Veeraragavan 54 M Chennai GPO 74312 MW 7 2    
45 Thanjammal 21 F Porur 92411 NMW 11 7    
46 Logammal 17 F Tondayarpet 92142 O 5 1      
47 Shyam Kumar 13 M Guindy 73149 O 7 4    
48 Jegan 24 M Anna Nagar 73227 MW 9 5    
49 Narayanan 47 M Mogapair 82723 MW 10 7      
50 Parvathy 36 F Washermenpet 94518 MW 11 3     
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51 Parimala 39 F Egmore 6352 O 4 2    
52 Nagaraju 45 M Anna Nagar 22944 MW 6 3    
53 Jayalakshmi 31 F Parrys 59077 NMW 5 3     
54 Sivakumar 32 M Velachery 74906 NMW 3 2     
55 Udayakumar 40 M Vadapalani 49239 MW 7 4       
56 Vijay 17 M Redhills 74239 MW 4 3      
57 Prema 42 F Ennore 82343 MW 5 2       
58 Muthu 37 M Arakonam 72491 NMW 5 4  
59 Vinnai 49 M Saidapet 74289 MW 7 5    
60 Kumar 32 M SIET 73921 NMW 3 2    
61 Kala 29 F Chrompet 82911 O 6 4    
62 Subramani 40 M Guindy 92129 NMW 7 4     
63 Anand 39 M Brodway 72193 MW 6 5        
64 Babu 21 M Thiruvetriyur 82144 S 5 3  
65 Santhose 43 M Kanchipuram 92311 MW 6 4   
66 Priya 34 F Anna Nagar 84429 NMW 8 5        
67 Leenus 49 M Chengalpet 92484 MW 4 2 
68 Prema 28 F Redhills 24948 NMW 3 3    
69 Murali 17 M Tambaram 42913 S 7 4   
70 Kannan 29 M Guindy 92144 MW 3 3   
71 Jeya 51 F Kilpauk 42001 MW 7 4   
72 Kanmani 41 F Anna Nagar 42103 NMW 9 6     
73 Arumugam 56 M Amjekarai 92193 O 4 2   
74 Sudhakar 35 M Porur 93281 MW 5 3    
75 Nithya 23 F Park Town 92319 S  7 3    
76 Sivakumar 18 M Chrompet 98844 S 4 4  
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77 Raja Prasad 17 M Tambaram 8219 MW 15 15  
78 Ravi 44 M Vennarpet 60278 NMW 5 5  
79 Kamalakannan 68 M Kodambakkam 63976 MW 3 3 
80 Rathan 39 M Porur 73142 MW 8 7 
81 Perumal 49 M Arakonam 74192 MW 4 3 
82 Venkatesan 38 M Porur 74093 MW 9 5  
83 Ramesh 40 M Kadpadi 72432 MW 5 5    
84 Sarulatha 51 F Redhills 78341 MW 7 3  
85 Kavin 17 M MMDA 87431 S 8 4    
86 Sundar 28 M SIET 78329 NMW 4 4   
87 Sathymoorthy 47 M Chrompet 48494 MW 7 6     
88 Sulan 24 M Kilpauk 74921 NMW 6 6
89 Nalini 32 F Egmore 78291 MW 5 3     
90 Saravanan 40 M Saligramam 74282 NMW 4 4
91 Jose 47 M Redhills 74884 MW 7 7     
92 Palani 37 M Egmore 82197 NMW 8 4    
93 Sudha 29 F Vadapalani 81429 MW 9 5  
94 Parthiban 27 M Tiruvallur 74889 NMW 5 5       
95 Mohan 37 M Gummidipondi 58224 MW 7 7  
96 Pandi 30 M Arakonam 58763 MW 15 15   
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1 Krishnaveni 7.1 4100 0.87 120 9.3 4.3 5.2 35 26 82 24 0.7 Neg Neg Neg Neg 2+ Ictero Splenomegaly Lepto Cured
2 Saradha 10.2 8900 1 40 38 28 10 168 76 122 174 2.9 Neg Neg Neg Neg 2+ Ictero N Lepto Expired
3 Vengat 10.2 6000 1 24 46 1.6 3 80 82 120 25 0.8 Neg Neg Neg Neg 2+ Autumnalis Hepatomegaly Lepto Cured
4 Vivek 8.4 7000 1 60 4.9 3.2 1.7 71 62 183 30 0.9 Neg Neg Neg Neg 2+ Grippotyphosa N Lepto Cured
5 Durai Singh 13.4 4400 0.31 10 2.1 1.5 0.6 58 82 169 38 0.8 Neg Neg Neg Neg 3+ Ictero N Lepto Cured
6 Ezhumalai 8.4 6400 0.9 58 5.1 2.3 2.8 38 46 172 90 1.2 Neg Neg Neg Neg 2+ Ictero N Lepto Cured
7 Varadharaj 11.1 6700 1.11 30 3 1.6 1.4 132 117 130 27 0.9 Neg Neg Neg Neg 2+ Semaranga N Lepto Cured
8 Siranjeevi 13.1 7100 3.33 6 6 3.4 2.6 75 55 88 28 1.0 Neg Neg Neg Neg 2+ Autumnalis Splenomegaly Lepto Cured
9 Sarangan 9.2 11000 0.5 32 2.2 1.8 0.4 58 42 132 180 8.0 Neg Neg Neg Neg 3+ Ictero N Lepto Expired
10 Suresh Kumar 11.3 12000 1.17 12 4.6 3 1.6 80 74 123 72 2.7 Neg Neg Neg Neg 3+ Ictero Hepatomegaly Lepto Cured
11 Jaya 12.1 7200 2.12 6 25.2 18 7.2 73 86 190 38 0.8 Neg Neg Neg Neg 2+ Australis N Lepto Cured
12 Batcha 9.4 8100 1.1 24 7.2 4.1 3.1 92 90 212 28 0.7 Neg Neg Neg Neg 2+ Semaranga N Lepto Cured
13 Nadhan 10.5 4230 1 36 4 2 2 48 45 120 42 1.1 Neg Neg Neg Neg 3+ Ictero N Lepto Cured
14 Stella Mary 8.9 5100 1.54 30 8.4 4 4.4 76 80 138 28 0.8 Neg Neg Neg Neg 2+ Semaranga N Lepto Cured
15 Neetu Yadav 11.4 4720 1.32 30 12.5 8 4.5 120 132 198 91 3.9 Neg Neg Neg Neg 2+ Ictero N Lepto Cured
16 Johnson 13.4 5200 1.78 42 20.1 10 10.1 212 300 212 140 7.0 Neg Neg Neg Neg 2+ Ictero Hepatomegaly Lepto Expired
17 Naresh 8.4 5400 1.62 28 12.4 6.8 5.6 110 112 162 112 4.2 Neg Neg Neg Neg 2+ Ictero N Lepto Cured
18 Rohitha 9.9 7100 2.42 14 3 1.6 1.4 70 70 128 36 9.0 Neg Neg Neg Neg 2+ Semaranga N Lepto Cured
19 Aswin 10.5 6400 0.48 8 10.5 6.3 4.2 108 110 142 32 1.1 Neg Neg Neg Neg 2+ Autumnalis N Lepto Cured
20 Nallasivam 11 7200 2.32 12 8.1 3.9 4.2 112 120 300 40 1.2 Neg Neg Neg Neg 2+ Semaranga N Lepto Cured
21 Jayalakshmi 10.7 5200 1.48 32 4.7 2.7 2 42 48 92 35 0.9 Neg Neg Neg Neg 2+ Semaranga N Lepto Cured
22 Vijayanthi 11.3 4900 1.62 26 6 3.2 2.8 52 48 112 37 0.9 Neg Neg Neg Neg 2+ Semaranga Hepatomegaly Lepto Cured
23 Harish 9.6 5400 1.32 18 7.2 4.1 3.1 68 72 120 28 0.6 Neg Neg Neg Neg 2+ Grippotyphosa N Lepto Cured
24 Ismail 10.3 7200 3 42 6.4 3.6 2.8 72 78 116 34 0.9 Neg Neg Neg Neg 2+ Semaranga N Lepto Cured
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25 Immanuel 10.4 7200 1.92 12 12.2 6.2 6 88 120 148 36 0.9 Neg Neg Neg Neg 2+ Australis N Lepto Cured
26 Kumara Raja 8.2 4100 1 12 8.6 4 4.6 50 45 96 92 3.6 Neg Neg Neg Neg 3+ Ictero N Lepto Cured
27 Gnanasundari 11.2 7200 1.72 32 14.2 8.4 5.8 40 36 112 40 1.0 Neg Neg Neg Neg 2+ Grippotyphosa N Lepto Cured
28 Ayyadurai 11.9 6100 1.68 28 4.2 2 2.2 52 48 102 36 0.9 Neg Neg Neg Neg 2+ Semaranga N Lepto Cured
29 Asaithambi 9.0 7200 1.9 16 6.8 4.2 2.6 46 50 96 29 0.7 Neg Neg Neg Neg 2+ Ictero Hepatosplenomegaly Lepto Cured
30 Sudha 10.0 6800 1.21 40 11.2 6.2 5 240 232 180 112 3.0 Neg Neg Neg Neg 2+ Ictero N Lepto Cured
31 Saritha 11.2 11000 2.4 18 11.4 6.1 5.3 40 36 126 68 2.1 Neg Neg Neg Neg 2+ Ictero N Lepto Cured
32 Leela Rani 11.4 10500 0.9 30 10.2 5.4 4.8 72 64 112 74 2.4 Neg Neg Neg Neg 3+ Autumnalis N Lepto Cured
33 Sampath 12.0 10000 2.8 24 4.8 3 1.8 90 92 140 39 0.9 Neg Neg Neg Neg 2+ Semaranga N Lepto Cured
34 Loganathan 10.8 6000 3.3 18 9.2 4.1 5.1 40 41 84 30 0.7 Neg Neg Neg Neg 2+ Semaranga Hepatomegaly Lepto Cured
35 Arumugam 14.0 7100 1.4 32 4.2 2.1 2.1 40 38 176 48 2.0 Neg Neg Neg Neg 2+ Australis Splenomegaly Lepto Cured
36 Kumar 12.0 7600 1.9 18 6.8 5 1.8 42 36 152 40 1.1 Neg Neg Neg Neg 2+ Grippotyphosa N Lepto Cured
37 Thusif 11.4 4800 2.4 36 11.2 7.1 4.1 40 44 86 80 3.2 Neg Neg Neg Neg 3+ Ictero Hepatomegaly Lepto Cured
38 Rajan 11.7 5100 2.2 8 10.4 5.8 4.6 42 40 92 128 6.1 Neg Neg Neg Neg 3+ Ictero N Lepto Expired
39 Naveen Kumar 10.2 5400 1.9 42 6.8 3.8 3 40 36 106 37 1.0 Neg Neg Neg Neg 2+ Semaranga N Lepto Cured
40 Priskilla 10.8 4900 0.31 40 5.4 3.4 2 42 38 112 54 1.7 Neg Neg Neg Neg 2+ Grippotyphosa N Lepto Cured
41 Manoj 10.0 5600 2.3 50 3.8 1.8 2 54 50 86 36 0.8 Neg Neg Neg Neg 2+ Semaranga N Lepto Cured
42 Sidharthan 13.0 8900 1.7 16 8.4 5.1 3.3 198 196 240 28 0.6 Neg Neg Neg Neg 2+ Semaranga N Lepto Cured
43 Rani 7.4 5900 1.7 8 10.2 5.1 5.1 40 36 118 70 2.8 Neg Neg Neg Neg 3+ Ictero Hepatomegaly Lepto Cured
44 Veeraragavan 10.0 7200 1.5 6 3.2 1.1 2.1 42 40 96 28 0.7 Neg Neg Neg Neg 2+ Ictero N Lepto Cured
45 Thanjammal 10.8 6000 1.9 12 4.2 2.8 1.4 38 45 64 71 3.1 Neg Neg Neg Neg 2+ Autumnalis N Lepto Expired
46 Logammal 8.4 7100 2 16 6.4 3 3.4 50 56 102 65 1.5 Neg Neg Neg Neg 2+ Grippotyphosa Hepatomegaly Lepto Cured
47 Shyam Kumar 10.2 4300 2.4 18 4.2 2.1 2.1 62 64 92 40 1.0 Neg Neg Neg Neg 2+ Ictero N Lepto Cured
48 Jegan 11.0 4000 2.6 32 3.8 2.1 1.7 40 36 112 29 1.0 Neg Neg Neg Neg 2+ Semaranga Hepatomegaly Lepto Cured
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49 Narayanan 11.0 5300 3 28 6.6 3.6 3 70 72 122 72 1.9 Neg Neg Neg Neg 2+ Ictero Hepatomegaly Lepto Cured
50 Parvathy 7.6 5500 1 16 4.2 2.2 2 84 90 142 35 0.7 Neg Neg Neg Neg 2+ Semaranga N Lepto Cured
51 Parimala 6.5 29800 1 28 6.6 5.2 1.4 80 56 102 144 3.8 PV Neg Neg Neg Neg Neg N Malaria cured
52 Nagaraju 10.5 3100 0.9 32 2 9.5 10.5 290 226 346 114 3.5 PF Neg Neg Neg Neg Neg Hepatosplenomegaly Malaria Expired
53 Jayalakshmi 9.1 8100 2.1 64 1.8 1.5 0.3 82 95 128 26 0.6 PV Neg Neg Neg Neg Neg N Malaria cured
54 Sivakumar 10.6 6000 0.65 24 5.2 1.5 3.7 30 73 110 70 1.4 PF Neg Neg Neg Neg Neg Splenomegaly Malaria cured
55 Udayakumar 7.6 9100 1.2 22 4 2 2 42 45 122 36 0.8 PF Neg Neg Neg Neg Neg N Malaria cured
56 Vijay 11 7900 2.1 28 2.2 1 1.2 40 47 110 37 0.7 PF Neg Neg Neg Neg Neg N Malaria cured
57 Prema 7.6 5300 0.91 22 6.8 1.8 5 221 248 278 82 2.7 PF Neg Neg Neg Neg Neg Splenomegaly Malaria cured
58 Muthu 11.7 9100 2.7 28 3.4 1.4 2 62 67 129 40 1.1 PF Neg Neg Neg Neg Neg Splenomegaly Malaria cured
59 Vinnai 13 9000 0.95 32 2.1 1 1.1 39 43 109 32 0.7 PV Neg Neg Neg Neg Neg N Malaria cured
60 Kumar 7.9 4700 1.27 24 3.1 1 2.1 49 40 123 48 1.2 PF Neg Neg Neg Neg Neg N Malaria cured
61 Kala 11.2 6900 1.58 32 2.4 1.2 1.2 38 43 120 28 0.7 PF Neg Neg Neg Neg Neg N Malaria cured
62 Subramani 7.4 5300 1.72 26 4.9 2.4 2.5 62 78 149 61 1.4 PF Neg Neg Neg Neg Neg Splenomegaly Malaria cured
63 Anand 12.7 9300 1.98 40 2.9 1.4 1.5 32 38 98 28 0.6 PV Neg Neg Neg Neg Neg N Malaria cured
64 Babu 8.4 4900 1.4 16 9 3 6 291 220 194 49 1.9 PF Neg Neg Neg Neg Neg Splenomegaly Malaria cured
65 Santhose 7 4100 1.2 24 4.3 1.3 3 92 80 162 42 1.1 PV Neg Neg Neg Neg Neg N Malaria cured
66 Priya 8.2 7300 2.2 24 3.1 1.1 2 49 42 134 36 0.9 PF Neg Neg Neg Neg Neg Splenomegaly Malaria cured
67 Leenus 11 7900 3.1 32 2.4 1.3 1.1 38 32 190 28 0.6 PF Neg Neg Neg Neg Neg N Malaria cured
68 Prema 8.6 4300 0.75 18 3.4 1.1 2.3 43 43 129 32 0.8 PF Neg Neg Neg Neg Neg N Malaria cured
69 Murali 13.2 11000 1.93 24 2.7 1.3 1.4 28 37 120 26 0.7 PV Neg Neg Neg Neg Neg N Malaria cured
70 Kannan 9.1 5900 1.12 28 3.1 1.2 1.9 48 43 136 32 0.8 PF Neg Neg Neg Neg Neg N Malaria cured
71 Jeya 8.9 7200 2.1 32 4 2.1 1.9 57 51 126 39 0.9 PV Neg Neg Neg Neg Neg Splenomegaly Malaria cured
72 Kanmani 7.6 5900 1.2 24 7.3 2.3 5 262 212 249 72 2.4 PF Neg Neg Neg Neg Neg Splenomegaly Malaria Expired
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73 Arumugam 11.2 9300 1.97 28 4 2 2 42 43 149 36 0.8 PF Neg Neg Neg Neg Neg N Malaria cured
74 Sudhakar 10.1 4000 2.9 26 2.6 0.8 1.8 51 43 103 28 0.7 PF Neg Neg Neg Neg Neg N Malaria cured
75 Nithya 12.90 4800 1.90 22.00 25.00 1.50 1.00 5240 3350 256 28 0.90 Neg + Neg Neg Neg Neg N Hepatitis A Cured
76 Siva 11.40 8500 3.17 18.00 10.00 7.00 3.00 229 81 223 19 0.70 Neg + Neg Neg Neg Neg Hepatomegaly Hepatitis A Cured
77 Raja Prasad 10.00 5800 2.10 20.00 8.00 6.20 1.80 512 422 204 25 0.80 Neg Neg + Neg Neg Neg Hepatomegaly Hepatitis B Cured
78 Ravi 10.30 5800 1.60 32.00 1.80 1.20 0.60 206 40 92 18 0.70 Neg Neg Neg + Neg Neg Hepatomegaly Hepatitis C Cured
79 Kamalakannan 8.90 13400 1.41 34.00 19.20 11.80 7.40 297 272 148 22 0.80 Neg Neg Neg + Neg Neg Hepatomegaly Hepatitis C Expired
80 Rathan 10.00 7200 2.40 18.00 10.50 7.20 3.30 620 500 212 34 0.90 Neg Neg + Neg Neg Neg N Hepatitis B Cured
81 Perumal 11.70 7100 1.91 16.00 11.50 7.50 4.00 711 522 342 30 0.80 Neg Neg Neg + Neg Neg N Hepatitis C Cured
82 Venkatesan 13.10 6300 1.79 22.00 7.10 3.00 4.10 210 204 282 30 0.70 Neg Neg + Neg Neg Neg Hepatomegaly Hepatitis B Cured
83 Ramesh 9.30 7100 1.82 32.00 6.80 4.10 2.70 221 210 182 26 0.90 Neg Neg + Neg Neg Neg Hepatomegaly Hepatitis B Cured
84 Sarulatha 11.00 4800 1.72 20.00 5.80 3.60 2.20 1042 986 256 32 0.80 Neg + Neg Neg Neg Neg N Hepatitis A Cured
85 Karin 13.00 6400 2.40 18.00 4.00 2.00 2.00 248 211 192 25 0.60 Neg + Neg Neg Neg Neg N Hepatitis A Cured
86 Sundar 9.90 7200 3.10 28.00 7.20 4.10 3.10 432 360 381 32 0.70 Neg Neg + Neg Neg Neg N Hepatitis B Cured
87 Sathya Moorthy 12.30 11000 2.70 30.00 9.30 5.60 3.70 291 240 202 29 1.00 Neg Neg Neg + Neg Neg Hepatomegaly Hepatitis C Cured
88 Sulan 11.00 9100 1.92 22.00 8.90 4.90 4.00 329 311 281 24 0.60 Neg Neg + Neg Neg Neg N Hepatitis B Cured
89 Nalini 10.70 8800 2.70 32.00 6.80 4.20 2.60 323 280 212 26 0.70 Neg Neg + Neg Neg Neg Hepatomegaly Hepatitis B Cured
90 Saravanan 9.90 8100 3.00 20.00 6.70 4.30 2.40 212 172 224 32 0.90 Neg Neg + Neg Neg Neg N Hepatitis B Cured
91 Jose 10.10 7200 3.20 24.00 7.20 4.00 3.20 411 411 301 40 1.00 Neg Neg Neg + Neg Neg N Hepatitis C Cured
92 Palani 11.20 7300 1.79 22.00 5.30 4.00 1.30 420 420 382 30 0.70 Neg Neg + Neg Neg Neg N Hepatitis B Cured
93 Sudha 10.50 7200 3.40 24.00 6.30 4.10 2.20 926 926 358 42 1.10 Neg Neg + Neg Neg Neg Hepatomegaly Hepatitis B Cured
94 Partion 12.10 13000 2.10 42.00 7.10 3.20 3.90 148 148 378 26 0.70 Neg Neg Neg Neg Neg Neg Pericholic Fluid GB Disease Expired
95 Mohan 12.70 24000 1.15 18.00 2.40 1.20 1.20 41 41 212 37 1.10 Neg Neg Neg Neg Neg Neg CBD stone GB Disease Cured
96 Pandi 10.00 14600 2.62 32.00 8.70 6.30 2.40 78 78 532 28 0.90 Neg Neg Neg Neg Neg Neg CBD stone GB Disease Cured
